UnitedHealth Group’s stock, the largest weighting in the Dow Jones Industrial Average, surged more than 6% following Donald Trump’s victory in the US presidential election. With Trump securing enough electoral votes to become the 47th president, and his Republican Party claiming a Senate majority, the stock market saw significant gains. The Dow Jones Industrial Average jumped over 3% on Wednesday, outperforming the S&P 500 and NASDAQ.
Stocks of health insurers, particularly those managing Medicare Advantage programs, saw a boost as a result of Trump’s win. The Biden administration had previously been focused on lowering reimbursement rates for senior healthcare, which created uncertainty for the industry. Companies specializing in Medicaid care, aimed at helping low-income individuals, experienced losses as Republicans are considered less favorable to this demographic.
UnitedHealth’s stock price reached nearly $600 as investors anticipated improved reimbursement rates for health insurers under a Trump presidency. Medicare Advantage programs, which are private versions of the government’s main enrollment program, were particularly favored by the market. Competitors like CVS Health and Humana also saw their stocks rise in response to the news.
While CVS Health exceeded revenue expectations in the third quarter, restructuring charges led to a profit loss in its Aetna segment. Stocks of companies focusing on Medicaid care, such as Elevance Health and Centene, declined amidst uncertainty about future government healthcare policies. UnitedHealth’s stock is currently approaching a resistance level at $608, which it has struggled to maintain in the past.
Investors are looking forward to maintaining the $608 price level as excitement about a Trump presidency grows. Despite a slight dip in UNH stock after reaching an intraday high of $605.50, traders are hopeful that the company will continue to perform well under a pro-business administration. Overall, UnitedHealth Group’s stock is poised to benefit from the changing political landscape and potential shifts in healthcare policy following the recent election results.
